NICE Conference 2026 speakers
Prof Jonathan Benger CBE
Chief executive, NICE
Dr Clare Morgan
Director of impact and partnerships, NICE
Richard Vize
Journalist and public policy analyst and NICE Conference 2026 chair
Prof Matthew Ashton
Director of public health, Liverpool City Council
Kiran Bali MBE JP
Lay member, NICE medical technologies advisory committee
Steve Bates
Executive chair, Office for Life Sciences
Nicola Bent
Chief executive, Health Innovation Wessex
Clara Bentham
Head of corporate affairs, UK and Ireland, Sanofi
Prof Rick Body
Professor of emergency medicine, University of Manchester and NICE committee chair
Kelly Broad
Deputy chief pharmacist, Cambridgeshire and Peterborough Integrated Care Board
Fleur Chandler
Advocacy and access specialist, Duchenne UK
Dr Mark Chavravarty
Non-executive director, NICE
Dr Nick Crabb
Chief scientific officer, NICE
Ross Dent
Associate director - medicines evaluation, NICE
Vincent Doyle
Associate director – engineering, NICE
Dr Louise Edwards
Programme director - implementation and insights, NICE
Sarah Fishburn
NICE guideline committee chair
Hayley Garnett
Head of content, NICE
Lesley Goodburn
Head of public involvement and engagement, NICE
Jano Goodchild
Participation and co-production director, Public Voice
Kirsty Hoyle
Chief executive officer, Metabolic Support UK
Johanna Hulme
head of medicines optimisation and pharmacy professional lead, NICE
Dr Amrita Jesurasa
National lead for prevention in clinical settings, Public Health Wales
Dr Andrew Jones BSc. MB BS MSc. (IS) MRCGP
Strategic advisor, head of digital transformation, Amazon Web Services (AWS)
Anita Kambo
Community and place-based researcher
Helen Knight
Director of medicines evaluation, NICE
David Lawson
Director of medical technology and innovation, Department of Health and Social Care
Sarah Le Brocq
Founder and director, All About Obesity
Prof Ewan Maule
Chief pharmacist and director of medicines and pharmacy, North East and North Cumbria ICB
Dr Rebecca McPhillips
Senior public engagement analyst – NICE Listens, NICE
Dr Nicole Mittmann
Chief scientist and vice-president of evidence, Canada's Drug Agency (CDA-AMC)
Prof Habib Naqvi
Chief executive, NHS Race and Health Observatory
Daniel A. Ollendorf, PhD, MPH
Chief scientific officer and director of health technology assessment (HTA) methods and engagement, Institute for Clinical and Economic Review (ICER)
Angela Osei
Associate director – national implementation, NICE
Dr John Patterson
GP clinical advisor, NICE
Dr Scott Purdon
Head of patient advocacy, Myeloma UK and chair of the Charity Medicines Access Coalition (CMAC)
Dr Keith Ridge CBE FRPharmS
Non-executive director, NICE
Thomas Slater
Director of healthtech and NICE Advice, NICE
Mark Sculpher
Professor and director of the Centre for Health Economics, University of York
Dr Leila Shepherd
Managing director, Helix Centre, Institute of Global Health Innovation at Imperial College London
Sarah Sleet
Chief executive officer, Asthma + Lung UK
John Spoors
Programme director - commercial, managed access and medicines policy, NICE
Lawrence Tallon
Chief executive, Medicines and Healthcare products Regulatory Agency (MHRA)
Dominic Wake
Head of corporate affairs, Sandoz Northern Cluster
Thomas Walker
Health technology assessment adviser, NICE
Bernadette Warren
Patient and NICE committee member
Dr Jacoline Bouvy
Deputy director of medicines evaluation, NICE